X T L Biopharmaceuticals reported $0 in Loan Capital for its fiscal quarter ending in December of 2024.





Loan Capital Change Date
Alaunos Therapeutics USD 4.47M 5.85M Jun/2022
Bioline Rx USD 2.22M 1.14M Jun/2026
Teva Pharmaceutical Industries USD 12.68B 588M Sep/2026
X T L Biopharmaceuticals USD 0 0 Dec/2024